Carl Zeiss Meditec AG (ETR:AFX - Get Free Report)'s stock price was up 1.8% on Wednesday . The company traded as high as €59.95 ($68.91) and last traded at €57.60 ($66.21). Approximately 278,528 shares changed hands during trading, an increase of 195% from the average daily volume of 94,405 shares. The stock had previously closed at €56.60 ($65.06).
Carl Zeiss Meditec Stock Performance
The company's 50-day simple moving average is €58.61 and its 200-day simple moving average is €56.68. The stock has a market cap of $5.27 billion, a price-to-earnings ratio of 30.25, a price-to-earnings-growth ratio of 2.83 and a beta of 0.98. The company has a quick ratio of 2.47, a current ratio of 2.13 and a debt-to-equity ratio of 7.41.
About Carl Zeiss Meditec
(
Get Free Report)
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
Before you consider Carl Zeiss Meditec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carl Zeiss Meditec wasn't on the list.
While Carl Zeiss Meditec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
